ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,562Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 298

$503K Total Retail Price of All Prescriptions

Rank: 31 out of 298

468 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 468 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

5% of this provider’s 468 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 11,783 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$37 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
SIMVASTATIN 693 650 1 2
LISINOPRIL 568 532 2 4
FUROSEMIDE 505 465 3 5
OMEPRAZOLE 478 398 4 3
LEVOTHYROXINE SODIUM 457 407 5 1
SERTRALINE HCL 401 365 6 19
AMLODIPINE BESYLATE 374 339 7 6
WARFARIN SODIUM 339 333 8 7
METFORMIN HCL 337 272 9 10
METOPROLOL TARTRATE 278 261 10 9
METOPROLOL SUCCINATE 266 237 11 12
CARVEDILOL 244 234 12 23
ATENOLOL 242 213 13 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 226 204 14 30
POTASSIUM CHLORIDE 196 191 15 11
DOXAZOSIN MESYLATE 174 154 16 77
TRAMADOL HCL 172 148 17 15
ALLOPURINOL 170 166 18 28
POLYETHYLENE GLYCOL 3350 144 83 19 29
GABAPENTIN 141 131 20 20
TRIAMTERENE-HCTZ 139 136 21 43
DIGOXIN 134 134 22 27
CITALOPRAM HBR 134 129 22 17
PREDNISONE 124 106 24 33
ATORVASTATIN CALCIUM 122 87 25 14
ISOSORBIDE MONONITRATE ER 120 116 26 45
DILTIAZEM ER 116 116 27 116
FINASTERIDE 116 70 27 66
FENOFIBRATE 108 74 29 62
RISPERIDONE 104 94 30 54
CLOPIDOGREL 104 104 30 36
CRESTOR 98 93 32 26
KLOR-CON 10 95 89 33 61
ZOLPIDEM TARTRATE 94 81 34 25
TERAZOSIN HCL 89 59 35 72
HYDROCHLOROTHIAZIDE 85 82 36 13
LOSARTAN POTASSIUM 84 66 37 18
GEMFIBROZIL 82 82 38 65
LANTUS SOLOSTAR 79 51 39 93
CLONIDINE HCL 79 77 39 82
BUPROPION HCL SR 77 73 41 133
SPIRONOLACTONE 76 76 42 34
TRAZODONE HCL 74 73 43 39
HYDROCODONE-ACETAMINOPHEN 70 59 S3 44 8
TAMSULOSIN HCL 68 56 45 24
DICLOFENAC SODIUM 63 39 46 138
LANTUS 63 48 46 53
BACLOFEN 60 31 48 97
LOSARTAN-HYDROCHLOROTHIAZIDE 60 56 48 44
CARBIDOPA-LEVODOPA 60 60 48 49
PAROXETINE HCL 59 46 51 48
PLAVIX 59 59 51 70
METOCLOPRAMIDE HCL 57 45 53 103
DILTIAZEM 24HR CD 55 50 54 74
DIOVAN 55 44 54 47
OXYBUTYNIN CHLORIDE 54 50 56 81
CIPROFLOXACIN HCL 53 48 57 56
METFORMIN HCL ER 52 52 58 57
SULFAMETHOXAZOLE-TRIMETHOPRIM 52 40 58 118
AMITRIPTYLINE HCL 52 28 R 58 51
MIRTAZAPINE 51 51 61 37
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 2, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.